{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:10:50Z","timestamp":1788311450884,"version":"build-2803163510"},"reference-count":180,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Institute on Minority Health and Health Disparities of the National Institutes of Health","award":["K01MD017631"],"award-info":[{"award-number":["K01MD017631"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Transgender\/gender-expansive (TGE) people, who use tobacco at high rates, are frequently advised not to use tobacco during gender-affirming hormone therapy (GAHT) due to the increased risk of negative health events. However, there is no summary of studies reporting the risk of negative health events for TGE people with versus without tobacco use during GAHT. This systematic review assesses what is known about tobacco use and health outcomes in studies of TGE people pursuing GAHT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Searches were conducted in PubMed, Embase, PsycInfo, Google Scholar, and Mednar. The protocol was registered in Prospero (CRD42023416390).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred and seven studies published from 1980 to 2024 mentioned tobacco and GAHT for TGE patients. Most studies focused on adults (80.4%). Patient samples were feminine\/transfeminine (29.9%), masculine\/transmasculine (26.2%), or \u201cboth\u201d\/combinations (43.0%). Most studies (96.3%) reported smoking prevalence, ranging from 4.2% to 73.0%. Forty-three studies (40.2%) explored patient outcomes as they related to GAHT and tobacco use, but significantly increased risk of adverse health events for TGE people receiving GAHT with tobacco use relative to no tobacco use was found in only five studies (4.7%). Tobacco cessation was not mentioned in 79.4% of studies, and no studies reported offering cessation assistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Identifying whether TGE people pursuing GAHT experience unique or exacerbated outcomes based on whether and what type of tobacco they use is critical for TGE-focused clinicians and researchers. This systematic review found few studies that identified empirical associations between tobacco use and GAHT-related health outcomes. Accurate tobacco assessment is essential to discern associations with GAHT-related outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications<\/jats:title>\n                    <jats:p>There are tobacco disparities for transgender and gender expansive (TGE) individuals and a growing demand for gender affirming hormone treatment (GAHT). This was the first systematic review of existing literature exploring the association between tobacco use and GAHT among TGE people. Results highlight the need for accurate tobacco use assessment and follow-up for patients pursuing GAHT in future studies exploring the association between tobacco use and GAHT-related outcomes. All healthcare professionals have TGE patients and should be aware of the risks between GAHT and tobacco, assess and record tobacco use accurately, and offer cessation assistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ntr\/ntaf158","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T12:08:16Z","timestamp":1754654896000},"page":"1891-1902","source":"Crossref","is-referenced-by-count":1,"title":["Reporting of Tobacco Use and Health Outcomes Among Transgender and Gender-Expansive People in Gender-Affirming Hormone Therapy Research: 1980\u20132024"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-8319","authenticated-orcid":false,"given":"Josephine T","family":"Hinds","sequence":"first","affiliation":[{"name":"Department of Psychological, Health, and Learning Sciences, University of Houston , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2048-6564","authenticated-orcid":false,"given":"Perel Y","family":"Wein","sequence":"additional","affiliation":[{"name":"Ferkauf Graduate School of Psychology, Yeshiva University , 1165 Morris Park Ave, Bronx, NY 10461,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Stern","sequence":"additional","affiliation":[{"name":"Ferkauf Graduate School of Psychology, Yeshiva University , 1165 Morris Park Ave, Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loriann","family":"Cioffi","sequence":"additional","affiliation":[{"name":"Ferkauf Graduate School of Psychology, Yeshiva University , 1165 Morris Park Ave, Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Cuddleston","sequence":"additional","affiliation":[{"name":"Ferkauf Graduate School of Psychology, Yeshiva University , 1165 Morris Park Ave, Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talya","family":"Gordon","sequence":"additional","affiliation":[{"name":"Ferkauf Graduate School of Psychology, Yeshiva University , 1165 Morris Park Ave, Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Delbourgo Patton","sequence":"additional","affiliation":[{"name":"D. Samuel Gottesman Library, Albert Einstein College of Medicine , 1300 Morris Park Avenue, Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7065-1349","authenticated-orcid":false,"given":"Andrea H","family":"Weinberger","sequence":"additional","affiliation":[{"name":"Ferkauf Graduate School of Psychology, Yeshiva University , 1165 Morris Park Ave, Bronx, NY 10461 ,","place":["USA"]},{"name":"Departments of Epidemiology and Population Health and Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine , 1300 Morris Park Ave., Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2025102119524999700_ref1","volume-title":"The Handbook of Lesbian, Gay, Bisexual, and Transgender Public Health","author":"Ferris","year":"2006"},{"key":"2025102119524999700_ref2","doi-asserted-by":"crossref","DOI":"10.4324\/9780203955055","volume-title":"The Transgender Studies Reader","author":"Stryker","year":"2013"},{"issue":"1","key":"2025102119524999700_ref3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/09540261.2015.1106446","article-title":"Non-binary or genderqueer genders","volume":"28","author":"Richards","year":"2016","journal-title":"Int Rev Psychiatry"},{"issue":"1","key":"2025102119524999700_ref4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1089\/trgh.2015.0001","article-title":"Mental health disparities within the LGBT population: a comparison between transgender and nontransgender individuals","volume":"1","author":"Su","year":"2016","journal-title":"Transgender Health"},{"issue":"3","key":"2025102119524999700_ref5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/lgbt.2014.0009","article-title":"Transgender health disparities: comparing full cohort and nested matched-pair study designs in a community health Center","volume":"1","author":"Reisner","year":"2014","journal-title":"LGBT Health"},{"issue":"5","key":"2025102119524999700_ref6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1037\/0033-2909.129.5.674","article-title":"Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence","volume":"129","author":"Meyer","year":"2003","journal-title":"Psychol Bull"},{"issue":"5","key":"2025102119524999700_ref7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1037\/a0029597","article-title":"A conceptual framework for clinical work with transgender and gender nonconforming clients: an adaptation of the minority stress model","volume":"43","author":"Hendricks","year":"2012","journal-title":"Prof Psychol Res Pract"},{"issue":"5","key":"2025102119524999700_ref8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1037\/a0016441","article-title":"How does sexual minority stigma \u201cget under the skin\u201d? A psychological mediation framework","volume":"135","author":"Hatzenbuehler","year":"2009","journal-title":"Psychol Bull"},{"key":"2025102119524999700_ref9","volume-title":"The Report of the 2015 U.S. Transgender Survey","author":"James","year":"2016"},{"issue":"1","key":"2025102119524999700_ref10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/09540261.2015.1115753","article-title":"Mental health and gender dysphoria: a review of the literature","volume":"28","author":"Dhejne","year":"2016","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"2025102119524999700_ref11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1037\/0033-2909.129.2.270","article-title":"Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking","volume":"129","author":"Kassel","year":"2003","journal-title":"Psychol Bull"},{"key":"2025102119524999700_ref12","doi-asserted-by":"publisher","first-page":"111356","DOI":"10.1016\/j.drugalcdep.2024.111356","article-title":"Minority stressors and tobacco use among a US sample of sexual and gender minority young adults","volume":"261","author":"Figueroa","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2025102119524999700_ref13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.amepre.2016.11.022","article-title":"Transgender use of cigarettes, cigars, and e-cigarettes in a national study","volume":"53","author":"Buchting","year":"2017","journal-title":"Am J Prev Med"},{"key":"2025102119524999700_ref14","doi-asserted-by":"publisher","first-page":"109268","DOI":"10.1016\/j.drugalcdep.2022.109268","article-title":"Nicotine\/tobacco use disparities among transgender and gender diverse adults: findings from wave 4 PATH data","volume":"232","author":"Sawyer","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"2025102119524999700_ref15","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1093\/ntr\/ntad048","article-title":"Prevalence of nicotine and tobacco product use by sexual identity, gender identity, and sex assigned at birth among emerging adult tobacco users in California, United States","volume":"25","author":"Krueger","year":"2023","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"2025102119524999700_ref16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/socf.12193","article-title":"The social costs of gender nonconformity for transgender adults: implications for discrimination and health","volume":"30","author":"Miller","year":"2015","journal-title":"Sociol Forum"},{"issue":"5","key":"2025102119524999700_ref17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/lgbt.2019.0005","article-title":"Cigarette smoking among youth at the intersection of sexual orientation and gender identity","volume":"6","author":"Wheldon","year":"2019","journal-title":"LGBT Health"},{"issue":"6","key":"2025102119524999700_ref18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jadohealth.2017.06.024","article-title":"Transgender youth substance use disparities: results from a population-based sample","volume":"61","author":"Day","year":"2017","journal-title":"J Adolesc Health"},{"issue":"2","key":"2025102119524999700_ref19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1037\/sgd0000167","article-title":"Affirmative practice with transgender and gender nonconforming youth: expanding the model","volume":"3","author":"Edwards-Leeper","year":"2016","journal-title":"Psychol Sex Orientat Gend Divers"},{"issue":"1","key":"2025102119524999700_ref20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1037\/cpp0000229","article-title":"Advancing the practice of pediatric psychology with transgender youth: state of the science, ongoing controversies, and future directions","volume":"6","author":"Chen","year":"2018","journal-title":"Clin Pract Pediatr Psychol"},{"issue":"2","key":"2025102119524999700_ref21","doi-asserted-by":"publisher","first-page":"e220978","DOI":"10.1001\/jamanetworkopen.2022.0978","article-title":"Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care","volume":"5","author":"Tordoff","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2025102119524999700_ref22","doi-asserted-by":"publisher","first-page":"e20153223","DOI":"10.1542\/peds.2015-3223","article-title":"Mental health of transgender children who are supported in their identities","volume":"137","author":"Olson","year":"2016","journal-title":"Pediatrics"},{"issue":"7","key":"2025102119524999700_ref23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/lgbt.2018.0103","article-title":"The relationship between tobacco use and legal document gender-marker change, hormone use, and gender-affirming surgery in a United States sample of trans-feminine and trans-masculine individuals: implications for cardiovascular health","volume":"5","author":"Kidd","year":"2018","journal-title":"LGBT Health"},{"issue":"Suppl 1","key":"2025102119524999700_ref24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of Care for the Health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgender Health"},{"issue":"3","key":"2025102119524999700_ref25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.NPR.0000819612.24729.c7","article-title":"An introduction to gender-affirming hormone therapy for transgender and gender-nonbinary patients","volume":"47","author":"Harris","year":"2022","journal-title":"Nurse Pract"},{"issue":"11","key":"2025102119524999700_ref26","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025102119524999700_ref27","doi-asserted-by":"publisher","first-page":"100173","DOI":"10.1016\/j.metop.2022.100173","article-title":"The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: a literature review","volume":"13","author":"Chan","year":"2022","journal-title":"Metab Open"},{"issue":"5","key":"2025102119524999700_ref28","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/jac\/dkaa016","article-title":"Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy","volume":"75","author":"Cirrincione","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2025102119524999700_ref29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/trgh.2015.0008","article-title":"A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals","volume":"1","author":"White Hughto","year":"2016","journal-title":"Transgender Health"},{"key":"2025102119524999700_ref30","volume-title":"USPATH and WPATH Confirm Gender-Affirming Health Care Is Not Experimental; Condemns Legislation Asserting Otherwise","author":"World Professional Association for Transgender Health","year":"2023"},{"key":"2025102119524999700_ref31","volume-title":"Advocating for the LGBTQ Community","author":"Anonymous","year":"2024"},{"issue":"1","key":"2025102119524999700_ref32","doi-asserted-by":"publisher","first-page":"e2023064292","DOI":"10.1542\/peds.2023-064292","article-title":"Prohibition of gender-affirming care as a form of child maltreatment: reframing the discussion","volume":"153","author":"Georges","year":"2023","journal-title":"Pediatrics"},{"key":"2025102119524999700_ref33","volume-title":"Endocrine Society Statement in Support of Gender-Affirming Care","author":"Anonymous","year":".."},{"key":"2025102119524999700_ref34","volume-title":"Attacks on Gender-Affirming and Transgender Health Care | ACP Online","author":"American College of Physicians","year":"2023"},{"key":"2025102119524999700_ref35","volume-title":"Prohibiting Gender-Affirming Medical Care for Youth","author":"Redfield","year":"2023"},{"issue":"6","key":"2025102119524999700_ref36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.21037\/tau.2016.09.04","article-title":"Hormone therapy for transgender patients","volume":"5","author":"Unger","year":"2016","journal-title":"Transl Androl Urol"},{"key":"2025102119524999700_ref37","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.25.23294637","article-title":"Hospitalization patterns, outcomes, and resource utilization among individuals with gender dysphoria: a nationwide study","author":"Uwumiro","year":"2023"},{"issue":"3","key":"2025102119524999700_ref38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jadohealth.2016.03.017","article-title":"Youth and caregiver perspectives on barriers to gender-affirming health Care for Transgender Youth","volume":"59","author":"Gridley","year":"2016","journal-title":"J Adolesc Health"},{"key":"2025102119524999700_ref39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-030-05683-4_2","volume-title":"Transgender Medicine: A Multidisciplinary Approach","author":"Safer","year":"2019"},{"issue":"2","key":"2025102119524999700_ref40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/MED.0000000000000227","article-title":"Barriers to health Care for Transgender Individuals","volume":"23","author":"Safer","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2025102119524999700_ref41","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordhb\/9780190673741.013.24","volume-title":"The Oxford Handbook of Global LGBT and Sexual Diversity Politics","author":"Edelman","year":"2020"},{"issue":"1","key":"2025102119524999700_ref42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/trgh.2018.0016","article-title":"Patient and parent experiences of Care at a Pediatric Gender Service","volume":"3","author":"Tollit","year":"2018","journal-title":"Transgender Health"},{"key":"2025102119524999700_ref43","volume-title":"Resolving the Current Injectable Estrogen Shortage: A Public Health Imperative","author":"Geffen","year":".."},{"issue":"1","key":"2025102119524999700_ref44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.15585\/mmwr.su7301a4","article-title":"Nonprescription hormone use among transgender women \u2014 national HIV Behavioral surveillance among transgender women, seven urban areas, United States, 2019\u20132020","volume":"73","author":"Olansky","year":"2024","journal-title":"MMWR"},{"issue":"12","key":"2025102119524999700_ref45","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1111\/jsm.12691","article-title":"People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge","volume":"11","author":"Mepham","year":"2014","journal-title":"J Sex Med"},{"issue":"4","key":"2025102119524999700_ref46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/lgbt.2014.0128","article-title":"Non-prescribed hormone use and barriers to Care for Transgender Women in San Francisco","volume":"2","author":"de Haan","year":"2015","journal-title":"LGBT Health"},{"issue":"2","key":"2025102119524999700_ref47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/15532739.2015.1075928","article-title":"Using photovoice, Latina transgender women identify priorities in a new immigrant-destination state","volume":"16","author":"Rhodes","year":"2015","journal-title":"Int J Transgenderism"},{"issue":"4","key":"2025102119524999700_ref48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2105\/AJPH.2007.132035","article-title":"Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City","volume":"99","author":"Sanchez","year":"2009","journal-title":"Am J Public Health"},{"key":"2025102119524999700_ref49","volume-title":"The Health Consequences of Smoking\u201450 Years of Progress: A Report of the Surgeon General","author":"US Department of Health and Human Services","year":"2014"},{"key":"2025102119524999700_ref50","volume-title":"Tobacco Fact Sheet","author":"World Health Organization (WHO)","year":"2023"},{"issue":"4","key":"2025102119524999700_ref51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7326\/M17-0577","article-title":"Cardiovascular disease among transgender adults receiving hormone therapy","volume":"167","author":"Streed","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025102119524999700_ref52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1568016052773270","article-title":"Smoking, Estradiol metabolism and hormone replacement therapy","volume":"3","author":"Mueck","year":"2005","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"issue":"n71","key":"2025102119524999700_ref53","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025102119524999700_ref54","volume-title":"EndNote","author":"The EndNote Team","year":"2013"},{"key":"2025102119524999700_ref55","volume-title":"Covidence","author":"Veritas Health Innovation","year":"2022"},{"key":"2025102119524999700_ref56","volume-title":"Lung, and Blood Institute. Study Quality Assessment Tools","author":"National Heart","year":"2023"},{"key":"2025102119524999700_ref57","doi-asserted-by":"publisher","DOI":"10.1089\/trgh.2023.0174","article-title":"Gender-affirming surgery and tobacco use: a systematic review","author":"Hinds","year":"2024","journal-title":"Transgender Health"},{"issue":"4","key":"2025102119524999700_ref58","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/ppc.12395","article-title":"LGBT friendly healthcare providers\u2019 tobacco treatment practices and recommendations","volume":"55","author":"Aleshire","year":"2019","journal-title":"Perspect Psychiatr Care"},{"issue":"7","key":"2025102119524999700_ref59","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamasurg.2021.0952","article-title":"Association between gender-affirming surgeries and mental health outcomes","volume":"156","author":"Almazan","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"2025102119524999700_ref60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jaip.2021.10.035","article-title":"Evaluation of allergic diseases in transgender and gender-diverse patients: a case study of asthma","volume":"10","author":"Arroyo","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2025102119524999700_ref61","doi-asserted-by":"crossref","first-page":"37005","DOI":"10.1038\/srep37005","article-title":"12-months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: a targeted metabolomics study","volume":"6","author":"Auer","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"2025102119524999700_ref62","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.japh.2023.08.001","article-title":"Effects of progesterone on gender affirmation outcomes as part of feminizing hormone therapy","volume":"64","author":"Bahr","year":"2024","journal-title":"J Am Pharm Assoc"},{"key":"2025102119524999700_ref63","doi-asserted-by":"publisher","first-page":"667403","DOI":"10.3389\/fendo.2021.667403","article-title":"Feminizing hormone therapy prescription patterns and cardiovascular risk factors in aging transgender individuals in Australia","volume":"12","author":"Balcerek","year":"2021","journal-title":"Front Endocrinol Lausanne"},{"issue":"1","key":"2025102119524999700_ref64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/jayao.2019.0070","article-title":"Gender affirming hormone replacement for the adolescent and young adult cancer survivor with hypogonadism","volume":"9","author":"Barthel","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2025102119524999700_ref65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.contraception.2021.11.001","article-title":"Intrauterine device, subdermal contraceptive, and depot medroxyprogesterone use among transmasculine and cisgender patients over a 10-year period","volume":"108","author":"Berglin","year":"2022","journal-title":"Contraception"},{"issue":"5","key":"2025102119524999700_ref66","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jsxm.2022.02.015","article-title":"Coming soon: ability to orgasm after gender affirming vaginoplasty","volume":"19","author":"Blasdel","year":"2022","journal-title":"J Sex Med"},{"issue":"4","key":"2025102119524999700_ref67","doi-asserted-by":"publisher","first-page":"873e","DOI":"10.1097\/prs.0000000000003225","article-title":"Top surgery in transgender men: how far can you push the envelope?","volume":"139","author":"Bluebond-Langner","year":"2017","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"2025102119524999700_ref68","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1089\/lgbt.2019.0213","article-title":"Behavioral health concerns and eligibility factors among adolescents and young adults seeking gender-affirming masculinizing top surgery","volume":"7","author":"Boskey","year":"2020","journal-title":"LGBT Health"},{"issue":"5","key":"2025102119524999700_ref69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/lgbt.2017.0057","article-title":"Transgender women living with HIV frequently take antiretroviral therapy and\/or feminizing hormone therapy differently than prescribed due to drug\u2013drug interaction concerns","volume":"4","author":"Braun","year":"2017","journal-title":"LGBT Health"},{"issue":"4","key":"2025102119524999700_ref70","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/ADM.0000000000000919","article-title":"Characterizing substance use disorders among transgender adults receiving Care at a Large Urban Safety net hospital","volume":"16","author":"Braun","year":"2022","journal-title":"J Addict Med"},{"issue":"732","key":"2025102119524999700_ref71","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.3399\/bjgp.2023.0023","article-title":"Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data","volume":"73","author":"Brown","year":"2023","journal-title":"Br J Gen Pr"},{"key":"2025102119524999700_ref72","doi-asserted-by":"crossref","first-page":"bcr0220091589","DOI":"10.1136\/bcr.02.2009.1589","article-title":"Findings that shed new light on the possible pathogenesis of a disease or an adverse effect: autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages","volume":"2009","author":"Bunck","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"6","key":"2025102119524999700_ref73","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/bjd.19812","article-title":"Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy","volume":"184","author":"Buonomo","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"2025102119524999700_ref74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.explore.2021.11.005","article-title":"\u201cI\u2019m a transgender man\u2026 I have to quit smoking for treatment and surgery\u201d: describing the experience of a Latino transgender man during his attempt to quit smoking","volume":"19","author":"Cartujano-Barrera","year":"2023","journal-title":"Explore NY"},{"key":"2025102119524999700_ref75","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2024.100177","article-title":"Three cases of thyroid cancer in transgender female veterans receiving gender-affirming estrogen treatment","volume":"15","author":"Christensen","year":"2024","journal-title":"Endocr Metab Sci"},{"issue":"6","key":"2025102119524999700_ref76","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae060","article-title":"Thyroid cancer prevalence, risk exposure, and clinical features among transgender female veterans","volume":"8","author":"Christensen","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"2025102119524999700_ref77","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.aace.2024.01.006","article-title":"Hematospermia in a transgender woman with evidence for endometrial tissue in the prostate","volume":"10","author":"Coleman-Belin","year":"2024","journal-title":"AACE Clin Case Rep"},{"issue":"12","key":"2025102119524999700_ref78","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytad562","article-title":"A case report of myocardial infarction in a young transgender man with testosterone therapy: raising awareness on healthcare issues in the transgender community and a call for further research","volume":"7","author":"Connelly","year":"2023","journal-title":"Eur Heart J Case Rep"},{"issue":"6","key":"2025102119524999700_ref79","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/lary.24480","article-title":"Voice in female-to-male transsexual persons after long-term androgen therapy","volume":"124","author":"Cosyns","year":"2014","journal-title":"Laryngoscope"},{"issue":"7","key":"2025102119524999700_ref80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/BF03350728","article-title":"Exogenous estrogen effect on lipid \/lipoprotein cholesterol in transsexual males","volume":"12","author":"Damewood","year":"1989","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"2025102119524999700_ref81","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2017-01927","article-title":"Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study","volume":"103","author":"de Blok","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025102119524999700_ref82","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S2213-8587(21)00185-6","article-title":"Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria","volume":"9","author":"de Blok","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2025102119524999700_ref83","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1210\/clinem\/dgaa841","article-title":"Sustained breast development and breast anthropometric changes in 3 years of gender-affirming hormone treatment","volume":"106","author":"de Blok","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025102119524999700_ref84","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10508-005-7926-5","article-title":"Sexual and physical health after sex reassignment surgery","volume":"34","author":"De Cuypere","year":"2005","journal-title":"Arch Sex Behav"},{"issue":"7","key":"2025102119524999700_ref85","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/humrep\/deaa133","article-title":"Impaired semen quality in trans women: prevalence and determinants","volume":"35","author":"de Nie","year":"2020","journal-title":"Hum Reprod"},{"issue":"2","key":"2025102119524999700_ref86","doi-asserted-by":"publisher","first-page":"e8451","DOI":"10.1002\/ccr3.8451","article-title":"Three cases highlighting possible discrepancies in the interpretation of transgender DXA scores","volume":"12","author":"De La Torre","year":"2024","journal-title":"Clin Case Rep"},{"issue":"3","key":"2025102119524999700_ref87","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/andr.12485","article-title":"Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence","volume":"6","author":"Defreyne","year":"2018","journal-title":"Andrology"},{"issue":"1","key":"2025102119524999700_ref88","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/olq.0000000000001072","article-title":"Recent penile sexual contact is associated with an increased odds of high-risk cervical human papillomavirus infection in transgender men","volume":"47","author":"Deutsch","year":"2020","journal-title":"Sex Transm Dis"},{"issue":"1","key":"2025102119524999700_ref89","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/ajhb.22203","article-title":"Associations between transition-specific stress experience, nocturnal decline in ambulatory blood pressure, and C-reactive protein levels among transgender men","volume":"24","author":"Dubois","year":"2012","journal-title":"Am J Hum Biol"},{"issue":"4","key":"2025102119524999700_ref90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/0092623X.2021.2000535","article-title":"TransCOVID: does gender-affirming hormone therapy play a role in contracting COVID-19?","volume":"48","author":"Durcan","year":"2022","journal-title":"J Sex Marital Ther"},{"issue":"3","key":"2025102119524999700_ref91","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00266-022-03213-x","article-title":"A single-center 10-year experience of 180 transmasculine patients undergoing gender-affirming mastectomy while continuing masculinizing hormone replacement therapy","volume":"47","author":"Ederer","year":"2022","journal-title":"Aesth Plast Surg"},{"issue":"1","key":"2025102119524999700_ref92","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ando.2021.11.004","article-title":"Characterization of a transgender population in Portugal","volume":"83","author":"Ferreira","year":"2022","journal-title":"Ann Endocrinol"},{"issue":"1","key":"2025102119524999700_ref93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.euroneuro.2014.11.019","article-title":"Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF)","volume":"25","author":"Fuss","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"2025102119524999700_ref94","first-page":"1260","article-title":"Endocrine management of transsexual: hormonal profiles of serum prolactin, testosterone, and estradiol","volume":"80","author":"Futterweit","year":"1980","journal-title":"N Y State J Med"},{"issue":"1","key":"2025102119524999700_ref95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/sap.0000000000001810","article-title":"A drain-free technique for female-to-male gender affirmation chest surgery decreases morbidity: outcomes from 306 consecutive masculoplasties","volume":"83","author":"Gallagher","year":"2019","journal-title":"Ann Plast Surg"},{"issue":"1","key":"2025102119524999700_ref96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/trgh.2018.0063","article-title":"Transcendendo: a cohort study of HIV-infected and uninfected transgender women in Rio de Janeiro, Brazil","volume":"4","author":"Garcia Ferreira","year":"2019","journal-title":"Transgender Health"},{"key":"2025102119524999700_ref97","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1677\/joe.1.06307","article-title":"The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects","author":"Giltay","year":"2005"},{"issue":"1","key":"2025102119524999700_ref98","doi-asserted-by":"publisher","first-page":"E39","DOI":"10.1097\/QAI.0000000000001767","article-title":"Cardiovascular risk profile of transgender women with HIV: a US health care database study","volume":"79","author":"Gogia","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"2025102119524999700_ref99","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/jsxmed\/qdad135","article-title":"Prevalence of pelvic pain in transgender individuals on testosterone","volume":"20","author":"Grimstad","year":"2023","journal-title":"J Sex Med"},{"issue":"7","key":"2025102119524999700_ref100","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jdcr.2020.04.036","article-title":"Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy","volume":"6","author":"Jackson Cullison","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"1","key":"2025102119524999700_ref101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13293-020-00332-5","article-title":"A community-based study of demographics, medical and psychiatric conditions, and gender dysphoria\/incongruence treatment in transgender\/gender diverse individuals","volume":"11","author":"James","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"4","key":"2025102119524999700_ref102","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/15532739.2017.1372838","article-title":"Investigating the outcome of the initial assessment at a national transgender health service: time to review the process?","volume":"18","author":"Jones","year":"2017","journal-title":"Int J Transgenderism"},{"issue":"2","key":"2025102119524999700_ref103","first-page":"124","article-title":"Cardiovascular disease risk factors among transgender women in Chiang Mai, Thailand","volume":"10","author":"Kulprachakarn","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"2025102119524999700_ref104","doi-asserted-by":"crossref","first-page":"116734","DOI":"10.1016\/j.socscimed.2024.116734","article-title":"Clinical and sociodemographic characteristics as predictors for quality of life in transmasculine and transfeminine individuals receiving gender-affirming hormone therapy","volume":"346","author":"Lad","year":"2024","journal-title":"Soc Sci Med"},{"issue":"2","key":"2025102119524999700_ref105","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/nrl.0000000000000226","article-title":"Stroke characteristics, risk factors, and outcomes in transgender adults: a case series","volume":"24","author":"LaHue","year":"2019","journal-title":"Neurologist"},{"issue":"3","key":"2025102119524999700_ref106","doi-asserted-by":"publisher","first-page":"27","DOI":"10.55563\/clinexprheumatol\/pq0qp6","article-title":"Pain and transition: evaluating fibromyalgia in transgender individuals","volume":"39","author":"Levit","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"2025102119524999700_ref107","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JCMA.0000000000000475","article-title":"Metabolic effects of cross-sex hormone therapy in transgender individuals in Taiwan","volume":"84","author":"Liu","year":"2021","journal-title":"J Chin Med Assoc"},{"issue":"6","key":"2025102119524999700_ref108","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1210\/clinem\/dgab089","article-title":"Erythrocytosis in a large cohort of trans men using testosterone: a long-term follow-up study on prevalence, determinants, and exposure years","volume":"106","author":"Madsen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025102119524999700_ref109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00238-016-1269-4","article-title":"Fatty degeneration of mammary glands in female-to-male transsexuals","volume":"40","author":"Makino","year":"2017","journal-title":"Eur J Plast Surg"},{"issue":"5","key":"2025102119524999700_ref110","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/s0735-1097(98)00416-1","article-title":"Vascular reactivity is impaired in genetic females taking high-dose androgens","volume":"32","author":"McCredie","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2025102119524999700_ref111","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/s0735-1097(97)00063-6","article-title":"Arterial reactivity is enhanced in genetic males taking high dose estrogens","volume":"29","author":"McCrohon","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2025102119524999700_ref112","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/trgh.2018.0002","article-title":"Associations between the length of time from transgender identity recognition to hormone initiation and smoking among transgender youth and young adults","volume":"3","author":"Menino","year":"2018","journal-title":"Transgender Health"},{"issue":"5","key":"2025102119524999700_ref113","doi-asserted-by":"crossref","first-page":"e2023064380","DOI":"10.1542\/peds.2023-064380","article-title":"Laboratory changes during gender-affirming hormone therapy in transgender adolescents","volume":"153","author":"Millington","year":"2024","journal-title":"Pediatrics"},{"issue":"2","key":"2025102119524999700_ref114","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/prs.0000000000001459","article-title":"Long-term outcomes of rectosigmoid neocolporrhaphy in male-to-female gender reassignment surgery","volume":"136","author":"Morrison","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"2025102119524999700_ref115","doi-asserted-by":"publisher","first-page":"e25860","DOI":"10.1002\/jia2.25860","article-title":"\u201cYou are not a man\u201d: a multi-method study of trans stigma and risk of HIV and sexually transmitted infections among trans men in Uganda","volume":"24","author":"Mujugira","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"2025102119524999700_ref116","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-023549","article-title":"Thrombosis risk in transgender adolescents receiving gender-affirming hormone therapy","volume":"147","author":"Mullins","year":"2021","journal-title":"Pediatrics"},{"issue":"1","key":"2025102119524999700_ref117","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4158\/EP161438.OR","article-title":"Increased rates of smoking cessation observed among transgender women receiving hormone treatment","volume":"23","author":"Myers","year":"2016","journal-title":"Endocr Pract"},{"issue":"6","key":"2025102119524999700_ref118","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/imj.14839","article-title":"Prevalence of polycythaemia with different formulations of testosterone therapy in transmasculine individuals","volume":"51","author":"Nolan","year":"2021","journal-title":"Intern Med J"},{"issue":"6","key":"2025102119524999700_ref119","doi-asserted-by":"crossref","first-page":"e12666","DOI":"10.1111\/and.12666","article-title":"Prolactin levels during short-and long-term cross-sex hormone treatment: an observational study in transgender persons","volume":"49","author":"Nota","year":"2017","journal-title":"Andrologia"},{"issue":"6","key":"2025102119524999700_ref120","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jvoice.2020.10.002","article-title":"Voice and gender incongruence: relationship between vocal self-perception and mental health of trans women","volume":"36","author":"Novais Valente Junior","year":"2022","journal-title":"J Voice"},{"issue":"5","key":"2025102119524999700_ref121","doi-asserted-by":"publisher","first-page":"729e","DOI":"10.1097\/prs.0000000000004926","article-title":"Creation of clitoral hood and labia minora in penile inversion vaginoplasty in circumcised and uncircumcised transwomen","volume":"142","author":"Opsomer","year":"2018","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"2025102119524999700_ref122","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/LGT.0000000000000510","article-title":"Vestibulovaginal sclerosis in a transgender man on testosterone","volume":"24","author":"O\u2019Sullivan","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"2025102119524999700_ref123","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy","volume":"93","author":"Ott","year":"2010","journal-title":"Fertil Steril"},{"issue":"8","key":"2025102119524999700_ref124","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1743-6109.2011.02311.x","article-title":"Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals","volume":"8","author":"Ott","year":"2011","journal-title":"J Sex Med"},{"issue":"6","key":"2025102119524999700_ref125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/trgh.2021.0160","article-title":"Mental health of transmasculine adults receiving gender-affirming hormone therapy in Thailand","volume":"8","author":"Pliensak","year":"2022","journal-title":"Transgender Health"},{"issue":"6","key":"2025102119524999700_ref126","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.amepre.2021.05.019","article-title":"Cardiovascular disease in a population-based sample of transgender and cisgender adults","volume":"61","author":"Poteat","year":"2021","journal-title":"Am J Prev Med"},{"issue":"6","key":"2025102119524999700_ref127","first-page":"201","article-title":"Two transgender men receiving subdermal testosterone pellets for gender affirmation","volume":"9","author":"Pulsiano","year":"2023","journal-title":"AACE Clin Case Rep"},{"issue":"1","key":"2025102119524999700_ref128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/trgh.2019.0061","article-title":"An observational study of hypertension and thromboembolism among transgender patients using gender-affirming hormone therapy","volume":"5","author":"Pyra","year":"2020","journal-title":"Transgender Health"},{"issue":"5","key":"2025102119524999700_ref129","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.endonu.2015.02.001","article-title":"Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia","volume":"62","author":"Quir\u00f3s","year":"2015","journal-title":"Endocrinol Nutr"},{"issue":"6","key":"2025102119524999700_ref130","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1046\/j.1365-2265.1998.00614.x","article-title":"The effects of oestrogen exposure on bone mass in male to female transsexuals","volume":"49","author":"Reutrakul","year":"1998","journal-title":"Clin Endocrinol"},{"key":"2025102119524999700_ref131","article-title":"Trends in feminizing hormone therapy for transgender patients, 2006\u20132017","author":"Rose","year":"2021","journal-title":"Transgender Health"},{"issue":"1","key":"2025102119524999700_ref132","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/sap.0000000000002712","article-title":"Gender-affirming mastectomy in transmasculine patients: does obesity increase complications or revisions?","volume":"87","author":"Rothenberg","year":"2021","journal-title":"Ann Plast Surg"},{"issue":"5S","key":"2025102119524999700_ref133","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1097\/sap.0000000000001414","article-title":"Does previous breast reduction affect the outcome of gender-affirming subcutaneous mastectomy?","volume":"80","author":"Salim","year":"2018","journal-title":"Ann Plast Surg"},{"issue":"4","key":"2025102119524999700_ref134","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jth.15256","article-title":"Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen","volume":"19","author":"Scheres","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2025102119524999700_ref135","doi-asserted-by":"crossref","first-page":"e0261312","DOI":"10.1371\/journal.pone.0261312","article-title":"The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis","volume":"17","author":"Schutte","year":"2022","journal-title":"PLoS One"},{"key":"2025102119524999700_ref136","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fpsyt.2021.621075","article-title":"Physical and sociodemographic features associated with quality of life among transgender women and men using gender-affirming hormone therapy","volume":"12","author":"Silva","year":"2021","journal-title":"Front Psych"},{"issue":"3","key":"2025102119524999700_ref137","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.xfre.2021.06.002","article-title":"The effect of estrogen therapy on spermatogenesis in transgender women","volume":"2","author":"Sinha","year":"2021","journal-title":"F Rep"},{"issue":"2","key":"2025102119524999700_ref138","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/cen.14985","article-title":"Gender-affirming hormone therapy effect on cortisol levels in trans males and trans females","volume":"100","author":"Sofer","year":"2024","journal-title":"Clin Endocrinol"},{"issue":"9","key":"2025102119524999700_ref139","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.jsxm.2019.06.014","article-title":"Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria","volume":"16","author":"Stoffers","year":"2019","journal-title":"J Sex Med"},{"issue":"7","key":"2025102119524999700_ref140","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/abm\/kaac072","article-title":"A qualitative examination of tobacco use and smoking cessation among gender minority adults","volume":"57","author":"Sun","year":"2023","journal-title":"Ann Behav Med"},{"issue":"1","key":"2025102119524999700_ref141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-016-0067-9","article-title":"Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis","volume":"7","author":"Tack","year":"2016","journal-title":"Biol Sex Differ"},{"issue":"1","key":"2025102119524999700_ref142","doi-asserted-by":"publisher","DOI":"10.4081\/jphr.2021.2090","article-title":"Associations between clusters of perceived social support level, depression, and suicidal ideation among transgender women: a latent class analysis","volume":"11","author":"Tantirattanakulchai","year":"2022","journal-title":"J Public Health Res"},{"issue":"1","key":"2025102119524999700_ref143","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/lgbt.2022.0027","article-title":"Incidence, contributing factors, and implications for clinical Management of Polycythemia in transmasculine patients on testosterone","volume":"10","author":"Tatarian","year":"2023","journal-title":"LGBT Health"},{"issue":"12","key":"2025102119524999700_ref144","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","article-title":"Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people","volume":"88","author":"Toorians","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025102119524999700_ref145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jbmr.4262","article-title":"Development of hip bone geometry during gender-affirming hormone therapy in transgender adolescents resembles that of the experienced gender when pubertal suspension is started in early puberty","volume":"36","author":"van Der Loos","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2025102119524999700_ref146","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jsxm.2021.05.013","article-title":"Long-term gender-affirming hormone therapy and cognitive functioning in older transgender women compared with cisgender women and men","volume":"18","author":"van Heesewijk","year":"2021","journal-title":"J Sex Med"},{"key":"2025102119524999700_ref147","first-page":"1","article-title":"Cognitive functioning in older transgender individuals receiving long-term gender-affirming hormone therapy","author":"van Heesewijk","year":"2023","journal-title":"Int J Transgender Health"},{"key":"2025102119524999700_ref148","doi-asserted-by":"publisher","first-page":"100816","DOI":"10.1016\/j.lanwpc.2023.100816","article-title":"Transgender-related stigma and gender minority stress-related health disparities in Aotearoa New Zealand: hypercholesterolemia, hypertension, myocardial infarction, stroke, diabetes, and general health","volume":"39","author":"Veale","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"10","key":"2025102119524999700_ref149","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/jbmr.3762","article-title":"Gender-affirming hormone treatment decreases bone turnover in transwomen and older transmen","volume":"34","author":"Vlot","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025102119524999700_ref150","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14779072.2019.1606713","article-title":"Cardiac arrhythmias secondary to hormone therapy in trans women","volume":"17","author":"Wamboldt","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"2025102119524999700_ref151","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/lgbt.2021.0400","article-title":"Factors associated with unsatisfactory pap tests among sexually active trans masculine adults","volume":"10","author":"Wang","year":"2023","journal-title":"LGBT Health"},{"issue":"7","key":"2025102119524999700_ref152","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jsxm.2020.06.023","article-title":"Urethral complications after metoidioplasty for genital gender affirming surgery","volume":"18","author":"Waterschoot","year":"2021","journal-title":"J Sex Med"},{"key":"2025102119524999700_ref153","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/2050313X211025922","article-title":"Fibromuscular dysplasia in a middle-aged transgender man: the role of hormones in disease pathogenesis","volume":"9","author":"Wheat","year":"2021","journal-title":"SAGE Open Med Case Rep"},{"issue":"6","key":"2025102119524999700_ref154","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jbmr.3102","article-title":"Bone mineral density increases in trans persons after 1 year of hormonal treatment: a Multicenter prospective observational study","volume":"32","author":"Wiepjes","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025102119524999700_ref155","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jbmr.3862","article-title":"Fracture risk in trans women and trans men using long-term gender-affirming hormonal treatment: a Nationwide cohort study","volume":"35","author":"Wiepjes","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2025102119524999700_ref156","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"issue":"4","key":"2025102119524999700_ref157","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2025102119524999700_ref158","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"4","key":"2025102119524999700_ref159","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0037-1608656","article-title":"Phalloplasty in female-to-male transsexuals by Gottlieb and Levine\u2019s free radial forearm flap technique-a long-term single-center experience over more than two decades","volume":"34","author":"Wirthmann","year":"2018","journal-title":"J Reconstr Microsurg"},{"issue":"9","key":"2025102119524999700_ref160","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/asj\/sjac091","article-title":"The effect of preoperative gender-affirming hormone therapy use on perioperative adverse events in transmasculine individuals undergoing masculinizing chest surgery for gender affirmation","volume":"42","author":"Wu","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"8","key":"2025102119524999700_ref161","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/head.14203","article-title":"Primary headaches among gender dysphoric female-to-male individuals: a cross-sectional survey on gender transition experience","volume":"61","author":"Yalinay Dikmen","year":"2021","journal-title":"Headache"},{"issue":"3","key":"2025102119524999700_ref162","doi-asserted-by":"publisher","DOI":"10.3316\/ielapa.560113783825647","article-title":"Hormonal medication for transsexuals","volume":"10","author":"Steinbeck","year":"2020","journal-title":"Venereology"},{"issue":"4","key":"2025102119524999700_ref163","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.eprac.2022.12.007","article-title":"Risk assessment and coronary artery calcium scoring in transgender and gender-diverse individuals receiving gender-affirming hormone therapy","volume":"29","author":"Duro","year":"2023","journal-title":"Endocr Pract"},{"issue":"5","key":"2025102119524999700_ref164","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.13441","article-title":"Gender-affirming hormone therapy: an updated literature review with an eye on the future","volume":"291","author":"D\u2019hoore","year":"2022","journal-title":"J Intern Med"},{"issue":"3","key":"2025102119524999700_ref165","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/00325481.2015.1015928","article-title":"The effects of cigarette smoking on male fertility","volume":"127","author":"Kovac","year":"2015","journal-title":"Postgrad Med"},{"issue":"2","key":"2025102119524999700_ref166","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/wps.20050","article-title":"The DSM-5: classification and criteria changes","volume":"12","author":"Regier","year":"2013","journal-title":"World Psychiatry"},{"issue":"4","key":"2025102119524999700_ref167","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab011","article-title":"Hormone therapy, mental health, and quality of life among transgender people: a systematic review","volume":"5","author":"Baker","year":"2021","journal-title":"J Endocr Soc"},{"key":"2025102119524999700_ref168","article-title":"Smoking and tobacco use; 50th anniversary surgeon General\u2019s report","author":"Health CO on S and","year":"2018"},{"issue":"10","key":"2025102119524999700_ref169","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1037\/0003-066X.54.10.817","article-title":"Does cigarette smoking cause stress?","volume":"54","author":"Parrott","year":"1999","journal-title":"Am Psychol"},{"issue":"1","key":"2025102119524999700_ref170","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12889-019-6592-9","article-title":"The impact of smoking cessation attempts on stress levels","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Public Health"},{"key":"2025102119524999700_ref171","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pmedr.2017.02.004","article-title":"Tobacco use cessation interventions for lesbian, gay, bisexual, transgender and queer youth and young adults: a scoping review","volume":"6","author":"Baskerville","year":"2017","journal-title":"Prev Med Rep"},{"issue":"12","key":"2025102119524999700_ref172","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/ntr\/ntw216","article-title":"Smoking cessation programs for lesbian, gay, bisexual, transgender, and intersex people: a content-based systematic review","volume":"19","author":"Berger","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"2025102119524999700_ref173","volume-title":"PhenX Toolkit","author":"Anonymous","year":".."},{"issue":"3","key":"2025102119524999700_ref174","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/aje\/kwr193","article-title":"The PhenX toolkit: get the most from your measures","volume":"174","author":"Hamilton","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2025102119524999700_ref175","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/tc-2022-057360","article-title":"Nicotine pouch marketing strategies in the USA: an analysis of Zyn, on! And velo","volume":"33","author":"Duan","year":"2024","journal-title":"Tob Control"},{"key":"2025102119524999700_ref176","doi-asserted-by":"publisher","first-page":"108068","DOI":"10.1016\/j.ypmed.2024.108068","article-title":"Popularity of Zyn and other nicotine pouch brands among U.S. adolescents, young adults, and adults in 2021","volume":"185","author":"Liu","year":"2024","journal-title":"Prev Med"},{"issue":"1","key":"2025102119524999700_ref177","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/prd.12395","article-title":"Oral and periodontal implications of tobacco and nicotine products","volume":"87","author":"Chaffee","year":"2021","journal-title":"Periodontol"},{"issue":"6","key":"2025102119524999700_ref178","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jama.2021.10366","article-title":"Nicotine pouch unit sales in the US, 2016-2020","volume":"326","author":"Marynak","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"2025102119524999700_ref179","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.amepre.2009.04.027","article-title":"Development of an instrument to document the 5A\u2019s for smoking cessation","volume":"37","author":"Lawson","year":"2009","journal-title":"Am J Prev Med"},{"issue":"9","key":"2025102119524999700_ref180","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s11606-017-4062-6","article-title":"Disparities in US healthcare provider screening and advice for cessation across chronic medical conditions and tobacco products","volume":"32","author":"Keith","year":"2017","journal-title":"J Gen Intern Med"}],"container-title":["Nicotine and Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntaf158\/63990337\/ntaf158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/27\/11\/1891\/63990337\/ntaf158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/27\/11\/1891\/63990337\/ntaf158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:53:07Z","timestamp":1761090787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/27\/11\/1891\/8228264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":180,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,8,8]]},"published-print":{"date-parts":[[2025,10,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntaf158","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,8,8]]}}}